Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · IEX Real-Time Price · USD
34.80
-1.63 (-4.47%)
At close: Jul 2, 2024, 4:00 PM
35.58
+0.78 (2.24%)
After-hours: Jul 2, 2024, 7:46 PM EDT
Immunocore Holdings Employees
Immunocore Holdings had 497 employees as of December 31, 2023. The number of employees increased by 89 or 21.81% compared to the previous year.
Employees
497
Change (1Y)
89
Growth (1Y)
21.81%
Revenue / Employee
$531,698
Profits / Employee
-$118,414
Market Cap
1.74B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 497 | 89 | 21.81% |
Dec 31, 2022 | 408 | 84 | 25.93% |
Dec 31, 2021 | 324 | 33 | 11.34% |
Dec 31, 2020 | 291 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Teladoc Health | 5,600 |
Evotec SE | 4,952 |
Zai Lab | 2,175 |
Veracyte | 815 |
Recursion Pharmaceuticals | 500 |
Harmony Biosciences Holdings | 246 |
Keros Therapeutics | 136 |
IMCR News
- 4 weeks ago - Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response - GlobeNewsWire
- 4 weeks ago - Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 - GlobeNewsWire
- 4 weeks ago - Immunocore to present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma - GlobeNewsWire
- 5 weeks ago - Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know. - Barrons
- 7 weeks ago - Immunocore reports first quarter financial results and provides a business update - GlobeNewsWire
- 2 months ago - Immunocore announces upcoming presentation and posters at ASCO 2024 - GlobeNewsWire
- 3 months ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire